当前位置: X-MOL 学术J Cataract Refract Surg › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Blue light-filtering and violet light-filtering hydrophobic acrylic foldable intraocular lenses: Intraindividual comparison.
Journal of Cataract & Refractive Surgery ( IF 2.8 ) Pub Date : 2019-10-01 , DOI: 10.1016/j.jcrs.2019.05.027
Shinichiro Nakano 1 , Akira Miyata 2 , Junya Kizawa 3 , Daijiro Kurosaka 3 , Kazunori Miyata 4 , Tetsuro Oshika 5
Affiliation  

PURPOSE To compare the clinical outcomes after cataract surgery and implantation of a blue light-filtering IOL (AcrySof IQ SN60WF) or a violet light-filtering intraocular lens (IOL) (OptiBlue ZCB00V). SETTING Four surgical sites in Japan. DESIGN Prospective case series. METHODS One eye of patients with bilateral cataract was randomly allocated to the blue light-filtering IOL and the fellow eye to the violet light-filtering IOL. Visual acuity and contrast sensitivity were assessed over 3 months. The incidence of cyanopsia was evaluated using the neutralization method. RESULTS The study enrolled 110 eyes of 55 patients. There was no significant difference in visual acuity between the two IOLs. Based on the neutralization results 1 week postoperatively, 15 cases (27.8%) with the light-filtering IOL and 8 cases (14.8%) with the violent light-filtering IOL had cyanopsia; the difference reached statistical significance (P = .049). After 2 weeks, the difference in the incidence of cyanopsia was not significant. Postoperative contrast sensitivity under photopic condition at 1 week and 3 months and contrast sensitivity under mesopic conditions at 3 months were significantly better with the violet light-filtering IOL than with the blue light-filtering IOL (P < .05). CONCLUSIONS The violet light-filtering IOL yielded highly satisfactory clinical outcomes, including reduction of cyanopsia and a potential improvement in contrast sensitivity. The different chromophores of the IOL and its different material and design might have contributed.

中文翻译:

蓝色滤光和紫色滤光疏水性丙烯酸折叠式人工晶状体:个性化比较。

目的比较白内障手术和植入蓝光滤光IOL(AcrySof IQ SN60WF)或紫光滤光人工晶状体(IOL)(OptiBlue ZCB00V)后的临床结果。设置日本的四个手术地点。设计预期案例系列。方法将双眼白内障患者的一只眼睛随机分配给蓝色滤光IOL,另一只眼睛分配给紫色滤光IOL。在3个月内评估视力和对比敏感度。使用中和法评估了蓝眼睛的发生率。结果该研究招募了55名患者的110只眼。两种IOL之间的视敏度无显着差异。根据术后1周的中和结果,使用滤光IOL的15例(27.8%)和8例(14。8%)用强光滤光的IOL曾有蓝眼病;差异达到统计学意义(P = .049)。2周后,紫癜的发生率差异无统计学意义。紫光滤光IOL在明视条件下术后1周和3个月的术后对比敏感度和中视镜条件在3个月时的对比敏感度明显好于蓝光滤光IOL(P <.05)。结论紫光滤光IOL取得了令人满意的临床结果,包括减少了蓝眼症和潜在的对比度敏感度改善。IOL的不同发色团及其不同的材料和设计可能是造成这种情况的原因。氰尿的发生率差异不显着。紫光滤光IOL在明视条件下术后1周和3个月的术后对比敏感度和中视镜条件在3个月时的对比敏感度明显好于蓝光滤光IOL(P <.05)。结论紫光滤光IOL取得了令人满意的临床结果,包括减少了蓝眼症和潜在的对比度敏感度改善。IOL的不同发色团及其不同的材料和设计可能有所贡献。氰尿的发生率差异不显着。紫光滤光IOL在明视条件下术后1周和3个月的术后对比敏感度和中视镜条件在3个月时的对比敏感度明显好于蓝光滤光IOL(P <.05)。结论紫光滤光IOL取得了令人满意的临床结果,包括减少了蓝眼症和潜在的对比度敏感度改善。IOL的不同发色团及其不同的材料和设计可能是造成这种情况的原因。紫光滤光IOL在明视条件下术后1周和3个月的术后对比敏感度和中视镜条件在3个月时的对比敏感度明显好于蓝光滤光IOL(P <.05)。结论紫光滤光IOL取得了令人满意的临床结果,包括减少了蓝眼症和潜在的对比度敏感度改善。IOL的不同发色团及其不同的材料和设计可能是造成这种情况的原因。紫光滤光IOL在明视条件下术后1周和3个月的术后对比敏感度和中视镜条件在3个月时的对比敏感度明显好于蓝光滤光IOL(P <.05)。结论紫光滤光IOL取得了令人满意的临床结果,包括减少了蓝眼症和潜在的对比度敏感度改善。IOL的不同发色团及其不同的材料和设计可能有所贡献。
更新日期:2019-09-26
down
wechat
bug